# Comparison of Gabapentin and Metoclopramide for Treating Hyperemesis Gravidarum

> **NCT02163434** · PHASE2 · COMPLETED · sponsor: **State University of New York at Buffalo** · enrollment: 31 (actual)

## Conditions studied

- Hyperemesis Gravidarum

## Interventions

- **DRUG:** Gabapentin
- **DRUG:** Metoclopramide

## Key facts

- **NCT ID:** NCT02163434
- **Lead sponsor:** State University of New York at Buffalo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2019-10
- **Final completion:** 2019-11
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2023-02-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02163434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02163434, "Comparison of Gabapentin and Metoclopramide for Treating Hyperemesis Gravidarum". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02163434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*